Calip GS - Search Results

1

Erythropoiesis-stimulating agents in sickle cell anaemia.

Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL. Han J, et al. Among authors: calip gs. Br J Haematol. 2018 Aug;182(4):602-605. doi: 10.1111/bjh.14846. Epub 2017 Jul 27. Br J Haematol. 2018. PMID: 28748552 Free PMC article. No abstract available.

2

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.

Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D. Mohyuddin GR, et al. Among authors: calip gs. Blood Cancer J. 2022 Dec 16;12(12):168. doi: 10.1038/s41408-022-00769-4. Blood Cancer J. 2022. PMID: 36526617 Free PMC article. No abstract available.

3

Changes in antibiotic prescribing by dentists in the United States, 2012-2019.

Ramanathan S, Yan CH, Hubbard C, Calip GS, Sharp LK, Evans CT, Rowan S, McGregor JC, Gross AE, Hershow RC, Suda KJ. Ramanathan S, et al. Among authors: calip gs. Infect Control Hosp Epidemiol. 2023 Nov;44(11):1725-1730. doi: 10.1017/ice.2023.151. Epub 2023 Aug 22. Infect Control Hosp Epidemiol. 2023. PMID: 37605940 Free PMC article.

4

Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022.

Guadamuz JS, Wang X, Royce TJ, Calip GS. Guadamuz JS, et al. Among authors: calip gs. JCO Oncol Pract. 2023 Dec;19(12):1206-1214. doi: 10.1200/OP.23.00144. Epub 2023 Sep 25. JCO Oncol Pract. 2023. PMID: 37748113 Free PMC article.

5

End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting.

Canavan M, Wang X, Ascha M, Miksad R, Showalter TN, Calip G, Gross CP, Adelson K. Canavan M, et al. J Clin Oncol. 2023 Oct 20;41(30):4729-4738. doi: 10.1200/JCO.22.02180. Epub 2023 Jun 20. J Clin Oncol. 2023. PMID: 37339389

6

Characterization of opioid use in sickle cell disease.

Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Han J, et al. Among authors: calip gs. Pharmacoepidemiol Drug Saf. 2018 May;27(5):479-486. doi: 10.1002/pds.4291. Epub 2017 Aug 16. Pharmacoepidemiol Drug Saf. 2018. PMID: 28815799 Free PMC article.

7

Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.

Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. Zhou J, et al. Among authors: calip gs. Br J Haematol. 2018 Jul;182(2):259-270. doi: 10.1111/bjh.15396. Epub 2018 May 16. Br J Haematol. 2018. PMID: 29767446 Free PMC article.

8

Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.

Zhou J, Han J, Nutescu EA, Patel PR, Sweiss K, Calip GS. Zhou J, et al. Among authors: calip gs. Pharmacotherapy. 2019 Jan;39(1):55-66. doi: 10.1002/phar.2197. Epub 2019 Jan 4. Pharmacotherapy. 2019. PMID: 30485471

9

Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. Zhou J, et al. Among authors: calip gs. Br J Haematol. 2019 Apr;185(1):116-127. doi: 10.1111/bjh.15773. Epub 2019 Feb 3. Br J Haematol. 2019. PMID: 30714090 Free PMC article.

10

The morbidity and mortality of end stage renal disease in sickle cell disease.

Viner M, Zhou J, Allison D, Han J, Molokie RE, Jain S, Gowhari M, Gordeuk VR, Calip G, Saraf SL. Viner M, et al. Am J Hematol. 2019 May;94(5):E138-E141. doi: 10.1002/ajh.25439. Epub 2019 Mar 1. Am J Hematol. 2019. PMID: 30773675 Free PMC article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page